In 2017, we offered weekly survey questions on topics ranging from standard tests, to new drugs, to opinions on CGMs, to personal exercise habits – and you answered. Here are the survey questions that drew the most response this year.
What would you like your A1c to be, regardless of your health? (This question is a favorite of our Publisher Steve Freed, and clearly of DIC readers as well: it had the highest number of responses this year, by a considerable margin.)
7% A1c: 8%
6% A1c: 20%
5% A1c: 56%
4% A1c: 12%
Questions on the basics of treatment – diagnosing prediabetes, diet, exercise, and when to prescribe metformin — were another popular category.
Would you treat a patient with an A1c of 5.7-5.9%, who has diabetes in their family history and is a few pounds overweight with elevated cholesterol, with metformin along with diet and exercise, or just diet and exercise to get started?
Just diet and exercise: 59%
Diet, exercise, and metformin: 40%
Which class of drugs would you prefer for a person with an A1c of 5.6%?
Just diet and exercise: 76%
At what A1c level would you recommend the use of metformin?
A1c 5.6%: 10%
A1c 5.7-5.9%: 28%
A1c 6.0%: 16%
A1c 6.1-6.2%: 6%
A1c 6.3-6.4%: 6%
A1c 6.5-7.0%: 33%
Which test do you use to determine if a patient has prediabetes?
Fasting blood sugar: 27%
Random blood sugar: 3%
What percent of your prediabetes patients are on metformin?
0% of patients: 4%
10% of patients: 18%
25% of patients: 28%
50% of patients: 20%
75% of patients: 30%
Overall, our respondents indicated positive experiences with & opinions of SGLT-2 inhibitor drugs.
Which new drug class have you seen the best results with in lowering A1c’s?
For a patient newly diagnosed with type 2 and an elevated A1c of 7-8%, would you consider an SGLT-2 drug as a second treatment option added to metformin if they are not at goal on metformin?
CGMs were a huge topic of conversation in 2017; DIC readers’ opinions on their impact are mixed.
Do you believe that glucose monitors will be a thing of the past as continuous glucose monitors (CGM) become less expensive and more accurate?
Not sure: 23%
And finally, many of you were eager to share your experience — or lack thereof — with Editor Dave Joffe’s favorite exercise, riding a bike. Results were, shall we say, all over the map.
When was the last time you rode a bike?
Thank you to our wonderful readers for all their contributions to making DIC a success in 2017!